Vaxcyte, Inc. (PCVX) Prices ~$1.0B Equity And 1.50% Converts

Vaxcyte priced 7.41M shares at $64, 400K pre-funded warrants, and $500M of 1.50% convertible notes due 2032 with an initial conversion price of ~$89.60. Gross proceeds are expected to be ~$1.0B, excluding underwriters’ options.Material DetailsContext by AI AnalystThis is a late-stage financing to f…